BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $7.3B
- YoY, 2025
- −13.6%
- 5-year CAGR
- −1.1%
- 10-year CAGR
- +4.1%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $7.3B | −13.6% |
| 2024 | $8.4B | +8.3% |
| 2023 | $7.8B | −0.5% |
| 2022 | $7.8B | +1.6% |
| 2021 | $7.7B | +0.4% |
| 2020 | $7.7B | +57.3% |
| 2019 | $4.9B | +7.0% |
| 2018 | $4.6B | −4.2% |
| 2017 | $4.8B | −4.6% |
| 2016 | $5.0B | +2.9% |
| 2015 | $4.8B | +0.4% |
| 2014 | $4.8B | −2.4% |
| 2013 | $4.9B | +17.0% |
| 2012 | $4.2B | +0.4% |
| 2011 | $4.2B | +14.0% |
| 2010 | $3.7B | −6.6% |
| 2009 | $3.9B | −4.7% |
| 2008 | $4.1B | +5.0% |
| 2007 | $3.9B | — |